CardioNet, headquartered in Pennsylvania, became an operating company in 1999, founded on an innovative, patented technology, the result of years of research and development. In the integration of cardiac monitoring, wireless communications, GPS and proprietary information management technologies, the CardioNet Mobile Cardiac Outpatient TelemetryTM (MCOTTM) system is the first to provide real-time ECG monitoring and 24/7/365 analysis and response for patients–at home, at work or traveling. In February 2002, CardioNet received FDA approval for its core monitoring technology and opened the first CardioNet Service Center in Philadelphia.
Recent NewsMore >>
DateTitle 
02/10/12CardioNet, Inc. Acquires ECG Scanning & Medical Services, Inc.
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Feb. 10, 2012-- CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today announced the acquisition of ECG Scanning & Medical Services, Inc. CardioNet acquired all of the outstanding shares of ECG Scanning for aggregate consideration of $5.8 million in cash at closing and up to an additional $0.6 million in cas... 
Printer Friendly Version
12/15/11CardioNet, Inc. Reaches Preliminary Agreement on Shareholders Litigation
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Dec. 15, 2011-- CardioNet, Inc. (NASDAQ: BEAT), a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today announced that it has reached a preliminary agreement to settle the West Palm Beach Police Pension Fund putative class action litigation that was previously disclosed in the Company’s public filings. The preliminary agreement must be documen... 
Printer Friendly Version
12/14/11CardioNet, Inc. Announces the Launch of its Next Generation MCOT(TM) Device
CONSHOHOCKEN, Pa., Dec 14, 2011 (BUSINESS WIRE) --CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today announced the launch of its next generation Mobile Cardiac Outpatient Telemetry device. Joseph Capper, President and Chief Executive Officer of CardioNet, commented: "The launch of this state-of-the-art system is further evidence of our commitment... 
Printer Friendly Version
12/14/11CardioNet, Inc. Announces the Launch of its Next Generation MCOT™ Device
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Dec. 14, 2011-- CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today announced the launch of its next generation Mobile Cardiac Outpatient Telemetry device. Joseph Capper, President and Chief Executive Officer of CardioNet, commented: “The launch of this state-of-the-art system is further eviden... 
Printer Friendly Version

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.


STOCK QUOTE
BEAT (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$2.93
Change (%) Stock is Up 0.06 (2.09%)
Volume26,351
Data as of 02/10/12
2:18 p.m. ET
Minimum 20 minute delay
Refresh quote

EMAIL ALERTS
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds
Copyright © CardioNet 2002-2009, All Rights Reservedprivacy policy/termssite mapinfo@cardionet.com